$41.92
-0.39-0.92%
At close: -
$41.92
0.000.00%
After Hours: 1:00 PM EDT
Comments
Loading...
Vera Therapeutics (VERA) Forecast
NewsEarningsVera Therapeutics (VERA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVera Therapeutics (NASDAQ:VERA) Stock Quotes, Forecast and News Summary
Vera Therapeutics Stock (NASDAQ: VERA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vera Therapeutics (VERA) stock?
You can purchase shares of Vera Therapeutics (NASDAQ:VERA) through any online brokerage.
Who are Vera Therapeutics (VERA) competitors?
Other companies in Vera Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for Vera Therapeutics (VERA) stock?
Vera Therapeutics has a consensus price target of $51.36.
What is the current price for Vera Therapeutics (VERA)?
The stock price for Vera Therapeutics (NASDAQ: VERA) is $41.92 last updated December 24, 2024 at 1:00 PM EST.
Does Vera Therapeutics (VERA) pay a dividend?
A quarterly cash dividend of 0.02 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on January 10, 1996.
When is Vera Therapeutics (NASDAQ:VERA) reporting earnings?
Vera Therapeutics’s Q4 earnings are confirmed for Wednesday, March 19, 2025.
Is Vera Therapeutics (VERA) going to split?
There is no upcoming split for Vera Therapeutics.
What sector and industry does Vera Therapeutics (VERA) operate in?
Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.